MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Human immunodeficiency virus [HIV] counseling (Z71.7)

Evalytics 01 April at 06.25 PM

HIV Remission in Children: A Hopeful Development

HIV remission in children, characterized by a sustained period of undetectable viral load without the need for antiretroviral therapy (ART), represents a significant breakthrough in pediatric HIV care. This phenomenon, observed in children who have undergone a pause in treatment, offers new insights into the management and potential cure of HIV/AIDS.

Evalytics 01 April at 06.07 PM

CDC alerts doctors to watch for rare, serious bacterial infection appearing with unusual symptoms

CDC alerts rising cases of rare, deadly meningococcal infections in middle-aged adults, caused by ST-1466 strain with atypical symptoms and higher mortality rate. Transmission via respiratory secretions, symptoms include fever, chills, rapid deterioration; urgent antibiotic treatment and vaccination recommended.

Evalytics 11 March at 01.28 AM

After decades of failures, researchers have renewed hopes for an effective HIV vaccine

Researchers are optimistic about developing an effective HIV vaccine after decades of setbacks. Recent advancements in understanding immune responses offer renewed hope. New vaccine candidates are showing promising results in early trials, sparking optimism for future HIV prevention strategies.

Evalytics 11 March at 01.26 AM

HIV Remission in Children: A Hopeful Development

Pediatric HIV remission, marked by prolonged undetectable viral load sans antiretroviral therapy (ART), is a notable advance. This condition, seen in children with treatment pauses, offers fresh perspectives on HIV/AIDS management and potential cure.

Evalytics 05 February at 08.29 PM

Scientists see an ultra-fast movement on surface of HIV virus

Duke researchers have identified a key moment in HIV infection, where the virus's envelope glycoprotein opens to attach to T-cells. This discovery offers new directions for AIDS vaccine development, focusing on antibodies that block this process, and marks a significant shift in understanding HIV's infection mechanism.

HealthDay 22 January at 04.48 PM

Risk Factor Control May Modify Link Between HIV Status and Heart Disease

Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.Michael J. Silverberg, Ph.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues conducted a retrosp

HealthDay 08 January at 11.43 PM

Increase in Out-of-Pocket Costs Could Increase Abandonment of HIV PrEP Meds

An increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adj

HealthDay 08 January at 11.43 PM

Increase in Out-of-Pocket Costs Could Increase Abandonment of HIV PrEP Meds

An increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adj

HealthDay 05 January at 10.20 PM

FDA Allows Florida to Import Cheaper Drugs From Canada

In what could prove to be a major turning point for the prescription drug market in the United States, the U.S. Food and Drug Administration has approved a Florida plan to import drugs from Canada.U.S. residents can now buy directly from Canadian pharmacies out of their own pockets, but state Medicaid programs have not been allowed to purcha

HealthDay 21 December at 04.13 PM

Doxycycline Postexposure Prophylaxis Does Not Avert STIs in Women

For Kenyan women receiving preexposure prophylaxis against HIV, the incidence of sexually transmitted infections (STIs) does not differ for those receiving doxycycline postexposure prophylaxis (PEP) compared with standard care, according to a study published in the Dec. 21 issue of the New England Journal of Medicine.Jenell Stewart, D

HealthDay 18 December at 10.29 PM

2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender Persons

From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published online Dec. 19 in the Annals of Internal Medicine.Ya-Lin A. Huang, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estim

HealthDay 30 November at 10.02 PM

Mortality Increased for Infants, Under 5s With HIV Receiving Antiretrovirals

More infants and children aged younger than 5 years with HIV receiving antiretroviral therapy (ART) die compared with those aged 5 years and older receiving ART, according to research published in the Dec. 1 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Nickolas T. Agathis, M.D., fr

HealthDay 28 November at 04.36 PM

Two-Week DAA Prophylaxis Prevents Hep C After Kidney Transplant

Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to a study published online Nov. 28 in the Annals of Internal Medicine.Niraj M. Desai, M.D., from the Johns Hopkins Univ

Evalytics 20 November at 06.23 PM

Nearly 450 patients at Massachusetts hospital may have been exposed to HIV, hepatitis

ChatGPT Nearly 450 patients at Salem Hospital in Massachusetts may have been exposed to hepatitis B, C, and HIV due to improper practices during endoscopy procedures over two years. The hospital corrected the issue, notified affected patients, and offered free screenings. The risk of infection is considered very low, with no reported infections from this incident. Salem Hospital and its parent com

HealthDay 16 November at 09.53 PM

First OTC Test for Chlamydia, Gonorrhea Approved by the FDA

On Wednesday, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple 2 Test, the first home test for chlamydia and gonorrhea.People will be able to buy the Simple 2 Test over-the-counter at a pharmacy, take a specimen at home, and send their sample to a designated laboratory for testing, the FDA

HealthDay 03 November at 03.36 PM

One in Four Young Sexual-, Gender-Minority Individuals May Experience Syphilis

One-quarter of young sexual and gender minorities (YSGM) have syphilis at some point in their lives, according to a study published online Oct. 10 in the Journal of Infectious Diseases.Casey D. Xavier Hall, M.P.H., Ph.D., from Florida State University in Tallahassee, and colleagues examined syphilis incidence and prevalence prospect

HealthDay 30 October at 04.07 PM

2018 to 2021 Saw Increase in HIV PrEP Provision for Adolescents

From 2018 to 2021, there was an increase in HIV preexposure prophylaxis (PrEP) provision among adolescents, especially among male and older adolescents, according to a study published online Oct. 30 in Pediatrics.Anne A. Kimball, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined t